FZD2 and neoplasm: Accompanying the reduction in tumor growth, Ki67+ proliferating cells were significantly reduced in both FZD2 siRNA groups by 42% in SK-N-AS, and 40% in SK-N-DZ xenografts (P < 0.001; Figure 4C, third panel and 4D).